Stock Quality:
Last 7 days
-9.1%
Last 30 days
-9.1%
Last 90 days
-14.3%
Trailing 12 Months
-72.7%
ADIL RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
| CEO | Mr. Cary John Claiborne MBA |
|---|---|
| WEBSITE | adialpharma.com |
| SECTOR | Healthcare |
| INDUSTRY | Biotechnology |
| EMPLOYEES | 16 |